-
Why The Crypto Market Excitement About An IPO Wave Faded
17 Apr 2025 15:12 GMT
Eli Lilly (LLY) stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds over the course of 40 weeks.
The news solidifies Lilly's lead in developing an oral treatment for obesity. It …
-
Safety worries spur Pfizer to drop another obesity pill
14 Apr 2025 23:59 GMT
… In a statement, Chris Boshoff, Pfizer’s top scientist, said the … development, the company said.
Pfizer still has other candidates in … among Wall Street analysts that Pfizer might turn to deals … raise $275 million in an initial public offering in January.
-
Pfizer Halts Development Of Oral Weight-Loss Pill After Liver Injury Case In Patient
14 Apr 2025 13:18 GMT
… the medication was stopped.
Pfizer had been testing multiple … however, developed liver injury.
Pfizer said that “after a … of investigational treatments," Pfizer’s chief scientific officer, … trends, stock updates, tax, IPO, banking finance, real estate, …
-
Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin
23 Apr 2025 23:00 GMT
… such as Takeda, Merck, AstraZeneca, Pfizer and Innovent; and research and … prospectus for its U.S. initial public offering, filed with the SEC on … Company for its Hong Kong initial public offering dated October 16, 2019, and …
-
Global IPO market overview
29 Mar 2025 00:17 GMT
… at 1,340 IPOs.
View full image: Global IPO deal value and … in select IPO hubs.
View full image: Top-10 IPOs, globally, … of large, private equity-backed IPOs, including pharmaceuticals business Galderma landing … £2.57 billion that enabled Pfizer to sell a 7.7 …
-
India: Kotak buys $122m stake in IPO-bound Tirupati as Affirma Capital exits
26 Mar 2025 15:45 GMT
… , Dr. Reddy’s, Torrent, Macleods, Pfizer, Lupin, and Dabur, and manufactures … ’s expansion plans and its IPO preparation.
Affirma manages over $4 … recently, KAAML backed India’s IPO-bound Neuberg Diagnostics with Rs …
-
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
21 Mar 2025 14:43 GMT
… Pharmaceuticals (ALNY) will take on Pfizer's (PFE) Vyndaqel and … enough for all three players.
Pfizer's Vyndaqel earned $5 … To Buy And Watch: Top IPOs, Big And Small Caps, Growth …
-
Updates on health agency nominees; New data from Pfizer, Beam; MASH startup weighs IPO; and more
15 Mar 2025 11:01 GMT
-
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
21 Apr 2025 11:00 GMT
… such as Takeda, AstraZeneca, Merck, Pfizer and Innovent; and research and … Company for its Hong Kong initial public offering dated October 16, 2019, and …
-
Aardvark Therapeutics Gets $94 Million IPO to Power Obesity Treatments
13 Feb 2025 18:15 GMT
… speculation with a $94 million initial public offering, putting itself on the … initially filed plans for its IPO in late January without … currently dominating the market.
The IPO comes after an $85 … 7 billion valuation in an IPO. Pfizer and Biohaven are both …
About
© 1995-2025